Altoida Celebrates Historic Day for Patients with Alzheimer’s Disease
Nearly two decades of research and innovation are allowing us to revolutionize brain health and be recognized for it.
Learn more about our announcements and newsworthy achievements as we continue to build the world’s first precision neurology platform.
Altoida Raises $6.3M Series A to Predict Alzheimer's Disease Risk Using Artificial Intelligence, Machine Learning and Augmented Reality
80 M Street SE, Suite 100 Washington, DC 20003 USA
@ Altoida 2022